Rethinking Antipsychotic Dosing: Lessons from the RADAR Trial
Jan 6, 2025
13:34
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
In this episode, we explore the RADAR trial's findings on antipsychotic dose reduction in schizophrenia. Can patients with chronic schizophrenia safely reduce or discontinue their antipsychotic medications without increasing relapse risk? The trial's results challenge common assumptions about medication reduction and provide crucial guidance for clinical practice.
Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D.
Psychopharmacology and Psychiatry Updates